EDITOR'S NOTE: After this month's issue of Patent Strategy & Management went to press, U.S. District Judge James Cacheris granted a motion by GlaxoSmithKline for a preliminary injunction blocking the U.S.
USPTO Implements New Rules Governing Continuing Applications and Claim Quantities
The second installment of this two-part series examines the U.S. Patent and Trademark Office's final rule as it relates to examination of claims, applications with patentably-indistinct claims, second-action final practice, and refund of excess-claim fees.
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.






